Verition Fund Management
REGN icon

Verition Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Verition Fund Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Sell
6,100
-600
-9% -$408K 0.02% 785
2026
Q1 		$5.18M Buy
+6,700
New +$5.13M 0.03% 564
2025
Q4 		– Sell
-500
Closed -$281K – 3868
2025
Q3 		$281K Hold
500
– – ﹤0.01% 3329
2025
Q2 		$263K Buy
+500
New +$279K ﹤0.01% 3260
2025
Q1 		– Sell
-900
Closed -$641K – 3652
2024
Q4 		$641K Sell
900
-6,100
-87% -$5.12M ﹤0.01% 2328
2024
Q3 		$7.36M Hold
7,000
– – 0.04% 582
2024
Q2 		$7.36M Hold
7,000
– – 0.04% 508
2024
Q1 		$6.74M Buy
7,000
+4,100
+141% +$3.9M 0.05% 506
2023
Q4 		$2.55M Buy
2,900
+2,600
+867% +$2.14M 0.02% 724
2023
Q3 		$247K Sell
300
-800
-73% -$629K ﹤0.01% 1849
2023
Q2 		$790K Buy
+1,100
New +$848K 0.01% 1011
2023
Q1 		– Sell
-5,100
Closed -$3.68M – 2489
2022
Q4 		$3.68M Sell
5,100
-300
-6% -$221K 0.06% 417
2022
Q3 		$3.72M Buy
+5,400
New +$3.4M 0.04% 565
2022
Q2 		– Sell
-6,400
Closed -$4.47M – 2935
2022
Q1 		$4.47M Buy
6,400
+1,000
+19% +$633K 0.05% 442
2021
Q4 		$3.41M Buy
+5,400
New +$3.32M 0.02% 550

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Verition Fund Management's REGN Position: Q2 2026 in Review

Verition Fund Management increased its Regeneron Pharmaceuticals (REGN) stake by 124% in Q2 2026, buying an estimated $1.25M and bringing the position to 3,312 shares worth $2.07M. The position accounts for 0.01% of the portfolio, ranked #1086.

Verition Fund Management first reported a position in REGN in Q2 2013 and has held it in 43 quarters since. The position peaked at $18.7M in Q4 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Verition Fund Management held 3,312 shares of Regeneron Pharmaceuticals worth $2.07M as of Q2 2026.
  • Verition Fund Management bought 1,834 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.25M.
  • Regeneron Pharmaceuticals made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1086 holding.
  • Verition Fund Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 43 quarters since.
  • Verition Fund Management's Regeneron Pharmaceuticals position peaked at $18.7M in Q4 2024.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.